18Kathawala M, Hirschfield GM
WADA prohibition remains in force for tested athletes regardless of regulatory changes elsewhere
Western blotting (WB), immunohistochemistry (IHC) and Immunofluorescence (IF) are adopted to investigate the hub targets expression and signaling pathway activation (e.g., PI3K-AKT pathway, estrogen receptor pathway)
This caution comes mainly from cosmetic formulators rather than dermatology trials, so it is not a firm rule
Analyses focused on a filtered subset of 697 surveys reflecting early treatment (90 days) and ER stimulant monotherapy
The typical escalation moves from 0.25 mg to 0.5 mg at week 5, then to 1 mg at week 9, followed by 1.7 mg at week 13, and finally reaching the full maintenance dose of 2.4 mg semaglutide with 2.4 mg cagrilintide at week 17